UPDATED Apr 17, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ORC | US$8.16 | -1.3% | -26.0% | US$429.1m | n/a | PB0.9x | E118.4% | 17.6% | ||
OPRT | US$2.13 | -7.4% | -46.1% | US$75.7m | US$3.50 | PB0.2x | E115.8% | n/a | ||
ENVA | US$58.99 | -3.8% | 22.4% | US$1.6b | US$69.17 | PE9.3x | E11.9% | n/a | ||
RJF | US$121.94 | -4.1% | 25.9% | US$25.5b | US$132.75 | PE14.8x | E5.9% | 1.5% | ||
SNEX | US$64.09 | -2.4% | -7.8% | US$2.0b | US$84.00 | PE9.1x | E1.7% | n/a | ||
AIHS | US$0.81 | 2.0% | -5.9% | US$7.3m | n/a | PS1.1x | n/a | n/a | ||
WT | US$8.68 | -5.4% | 34.6% | US$1.3b | US$10.72 | PE13.4x | E0.8% | 1.4% | ||
EVR | US$185.50 | -3.1% | 50.3% | US$8.0b | US$207.00 | PE28.1x | E26.9% | 1.6% | ||
DFS | US$119.89 | -2.8% | 13.4% | US$30.0b | US$135.31 | PE10.5x | E5.8% | 2.3% |